HIV Care and Services Outside the US
The Latest
This Week in HIV Research: How Many Pills Can a Person Miss?
Nov. 20, 2019: Adherence required to maintain suppression; the accuracy of Framingham scores in assessing cardiovascular risk; long-term success rates for kidney transplants; integration of hypertension services with HIV care.
When Providers Don't Use Gender-Affirming Language, It Negatively Impacts HIV-Positive Transgender Women's Health
A new study shows that helping clinicians use gender-affirming language is important for transgender women in care. But we need more research on how HIV medications and feminizing hormones interact.
NIH, Gates Foundation Hatch Plan to Develop Affordable Gene Therapy for HIV, Sickle Cell Disease
The new public-private partnership will put $200 million toward finding eventual cures for two of the world's most pervasive diseases.
IDWeek 2019: What to Expect at This Year's Conference
We're covering the latest news and research from this major interdisciplinary meeting on infectious diseases, which takes place in Washington, D.C., from Oct. 2 to Oct. 6.
Global Health Researchers and Activists Grapple With Complex Needs of Migrants Living With HIV
Recent Trump administration policies on migrants living with HIV have prompted a response from the international AIDS research community.
Meet Young People on Their Own Terms and Don’t Judge Their Sex Lives, Experts Agree
Nonjudgmental services and innovative ways to talk to youth about sex should be at the core of any sexual health plan.
Indigenous Communities in Mexico and Elsewhere Demand a Seat at the Table
"We have never been silent, but you have not heard us": Advocates demonstrate to demand inclusion of indigenous issues in the HIV response.
Controversy Erupts Around Study on Contraception and HIV Risk
The ECHO trial faces backlash and criticism.
Marginalized Groups Are Focus of IAS 2019 Forum
Activists working on human rights discuss the challenges of achieving an end to the HIV epidemic.
Experts Flummoxed By Conflicting New Data on STIs, HIV, and Long-Term Contraception in Sub-Saharan Africa
ECHO trial results and follow-up studies find unexpectedly low rates of some STIs among users of certain long-term hormonal contraceptives. They also find high HIV rates (unrelated to the contraceptives) that suggest considerable value for PrEP integration.